The TELEX trial will establish whether telmisartan alone improves walking performance in
people with peripheral artery disease (PAD). The TELEX trial will also determine whether
telmisartan plus supervised exercise improves walking performance more than either therapy
alone. TELEX is a randomized controlled clinical trial (2 x 2 factorial design) of 112
participants with PAD randomized to one of four arms: Group A: telmisartan + supervised
exercise therapy; Group B: telmisartan + a "no exercise" control group; Group C: placebo +
supervised exercise therapy; and Group D: placebo + a "no exercise" control group.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.